Riemer H J A Slart, Marija Punda, Dalal S Ali, Alberto Bazzocchi, Oliver Bock, Pauline Camacho, John J Carey, Anita Colquhoun, Juliet Compston, Klaus Engelke, Paola A Erba, Nicholas C Harvey, Diane Krueger, Willem F Lems, E Michael Lewiecki, Sarah Morgan, Kendall F Moseley, Christopher O'Brien, Linda Probyn, Yumie Rhee, Bradford Richmond, John T Schousboe, Christopher Shuhart, Kate A Ward, Tim Van den Wyngaert, Jules Zhang-Yin, Aliya A Khan
{"title":"Updated practice guideline for dual-energy X-ray absorptiometry (DXA).","authors":"Riemer H J A Slart, Marija Punda, Dalal S Ali, Alberto Bazzocchi, Oliver Bock, Pauline Camacho, John J Carey, Anita Colquhoun, Juliet Compston, Klaus Engelke, Paola A Erba, Nicholas C Harvey, Diane Krueger, Willem F Lems, E Michael Lewiecki, Sarah Morgan, Kendall F Moseley, Christopher O'Brien, Linda Probyn, Yumie Rhee, Bradford Richmond, John T Schousboe, Christopher Shuhart, Kate A Ward, Tim Van den Wyngaert, Jules Zhang-Yin, Aliya A Khan","doi":"10.1007/s00259-024-06912-6","DOIUrl":null,"url":null,"abstract":"<p><p>The introduction of dual-energy X-ray absorptiometry (DXA) technology in the 1980s revolutionized the diagnosis, management and monitoring of osteoporosis, providing a clinical tool which is now available worldwide. However, DXA measurements are influenced by many technical factors, including the quality control procedures for the instrument, positioning of the patient, and approach to analysis. Reporting of DXA results may be confounded by factors such as selection of reference ranges for T-scores and Z-scores, as well as inadequate knowledge of current standards for interpretation. These points are addressed at length in many international guidelines but are not always easily assimilated by practising clinicians and technicians. Our aim in this report is to identify key elements pertaining to the use of DXA in clinical practice, considering both technical and clinical aspects. Here, we discuss technical aspects of DXA procedures, approaches to interpretation and integration into clinical practice, and the use of non-bone mineral density measurements, such as a vertebral fracture assessment, in clinical risk assessment.</p>","PeriodicalId":11909,"journal":{"name":"European Journal of Nuclear Medicine and Molecular Imaging","volume":" ","pages":"539-563"},"PeriodicalIF":8.6000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11732917/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Nuclear Medicine and Molecular Imaging","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00259-024-06912-6","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/24 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
The introduction of dual-energy X-ray absorptiometry (DXA) technology in the 1980s revolutionized the diagnosis, management and monitoring of osteoporosis, providing a clinical tool which is now available worldwide. However, DXA measurements are influenced by many technical factors, including the quality control procedures for the instrument, positioning of the patient, and approach to analysis. Reporting of DXA results may be confounded by factors such as selection of reference ranges for T-scores and Z-scores, as well as inadequate knowledge of current standards for interpretation. These points are addressed at length in many international guidelines but are not always easily assimilated by practising clinicians and technicians. Our aim in this report is to identify key elements pertaining to the use of DXA in clinical practice, considering both technical and clinical aspects. Here, we discuss technical aspects of DXA procedures, approaches to interpretation and integration into clinical practice, and the use of non-bone mineral density measurements, such as a vertebral fracture assessment, in clinical risk assessment.
期刊介绍:
The European Journal of Nuclear Medicine and Molecular Imaging serves as a platform for the exchange of clinical and scientific information within nuclear medicine and related professions. It welcomes international submissions from professionals involved in the functional, metabolic, and molecular investigation of diseases. The journal's coverage spans physics, dosimetry, radiation biology, radiochemistry, and pharmacy, providing high-quality peer review by experts in the field. Known for highly cited and downloaded articles, it ensures global visibility for research work and is part of the EJNMMI journal family.